TRCT
RBOT

Tower Research Capital (TRC)’s Vicarious Surgical RBOT Stock Holding History

Tower Research Capital (TRC)’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,572
Closed -$7.75K – 5486
2025
Q4 		$7.75K Buy
3,572
+3,351
+1,516% +$13.6K ﹤0.01% 3990
2025
Q3 		$1.22K Buy
+221
New +$1.69K ﹤0.01% 4841
2025
Q2 		– Sell
-147
Closed -$964 – 5520
2025
Q1 		$964 Sell
147
-329
-69% -$3.89K ﹤0.01% 4792
2024
Q4 		$6.26K Sell
476
-548
-54% -$5.64K ﹤0.01% 4189
2024
Q3 		$5.82K Sell
1,024
-671
-40% -$4.46K ﹤0.01% 4214
2024
Q2 		$9.95K Buy
1,695
+730
+76% +$6.53K ﹤0.01% 4192
2024
Q1 		$8.74K Buy
965
+148
+18% +$1.76K ﹤0.01% 3969
2023
Q4 		$9K Buy
817
+472
+137% +$5.26K ﹤0.01% 4449
2023
Q3 		$6.12K Sell
345
-9
-3% -$328 ﹤0.01% 4643
2023
Q2 		$19.4K Buy
354
+79
+29% +$5.03K ﹤0.01% 3407
2023
Q1 		$19K Buy
275
+84
+44% +$6.53K ﹤0.01% 3503
2022
Q4 		$12K Buy
191
+80
+72% +$7.44K ﹤0.01% 3735
2022
Q3 		$11K Sell
111
-130
-54% -$15.1K ﹤0.01% 4458
2022
Q2 		$21K Buy
241
+233
+2,913% +$28.5K ﹤0.01% 3754
2022
Q1 		$1K Sell
8
-10
-56% -$1.86K ﹤0.01% 5842
2021
Q4 		$6K Buy
18
+16
+800% +$5.64K ﹤0.01% 5059
2021
Q3 		$1K Buy
+2
New +$633 ﹤0.01% 5521

Other funds holding RBOT

AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
FFG
Forum Finance Group Geneva $184M AUM
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return

Tower Research Capital (TRC)'s RBOT Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 3,572 shares — an estimated $7.75K sold.

Tower Research Capital (TRC) first reported a position in RBOT in Q3 2021 and held it in 17 quarters. The position peaked at $21K in Q2 2022. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,572 Vicarious Surgical shares in Q1 2026, an estimated $7.75K.
  • Tower Research Capital (TRC) first reported a position in Vicarious Surgical in Q3 2021 and held it in 17 quarters.
  • Tower Research Capital (TRC)'s Vicarious Surgical position peaked at $21K in Q2 2022.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.